Comparing Avatar Therapy and Cognitive Behavioural Therapy for Hearing Voices
Official title: Remotely Delivered Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Auditory Hallucinations: Randomised Controlled Superiority Trial
Run by Swinburne University of Technology · NCT05982158 · Data updated 2026-11-12
This study is testing whether Avatar Therapy can help people with long-term hearing voices feel better compared to standard Cognitive Behavioural Therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 212 (estimated) |
| Sponsor | Swinburne University of Technology Academic / other |
| Locations | 1 site (Hawthorn, Victoria) |
| Status | Recruiting |
| Started | August 8, 2023 |
| Main results expected | December 2026 |
| Study ends | June 2027 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT05982158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and over with a diagnosis of schizophrenia-related disorders or mood disorders with psychotic symptoms, who have experienced persistent auditory verbal hallucinations for at least one year.
✕Probably not a fit
Patients who do not experience auditory verbal hallucinations or those who have not tried multiple antipsychotic medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of Avatar Therapy, an innovative psychological treatment, against the standard Cognitive Behavioural Therapy (CBT) for individuals experiencing persistent auditory verbal hallucinations (AVHs) associated with psychotic disorders. Participants will be randomly assigned to receive either therapy, with the goal of determining which approach leads to greater reductions in the severity of AVHs. The study focuses on individuals who have not responded adequately to traditional antipsychotic medications and have been living with these symptoms for at least a year. By utilizing avatars to recreate the voices during therapy, the study seeks to provide a more effective treatment option for this challenging symptom.
Why it matters
Potential benefit: If successful, this study could offer a new and more effective treatment option for patients suffering from distressing auditory hallucinations.
How similar studies have gone: Preliminary trials of avatar therapy have shown promising results, indicating potential success for this novel approach compared to traditional therapies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Schizophrenia-related disorder or a mood disorder with psychotic symptoms diagnosis confirmed using the Structured Clinical Interview for DSM (SCID) * Experiencing current auditory verbal hallucinations as measured by the Positive and Negative Syndrome Scale (PANSS) item P3 ≥ 4 * Auditory verbal hallucinations present for at least one year * AVHs include significant negative content (PSYRATS item 6 ≥ 2) and/or AVHs are distressing (PSYRATS item item 9 ≥ 2) * Current treatment with antipsychotic medication, or has been treated with antipsychotic medication in the past, with at least two different antipsychotic compounds, and these have been discontinued due to insufficient treatment response and/or poor tolerability. * Access to the internet and a computer or other device on which videoconferencing software can be used * Sufficient fluency in English for meaningful participation * Age 18 or over * Ability to give informed consent Exclusion Criteria: * Auditory verbal hallucinations attributable to a primary substance use disorder or organic disorder * Estimated full scale IQ \< 70 (using the Test of Premorbid Functioning, TOPF) * Within the last month or planned at the time of intake: a change of antipsychotic medication, * Current or within the past 3 months receipt of individual psychological therapy for hearing voices, or receipt of electro-convulsive therapy or other brain stimulation treatment; * AVHs in a language not spoken by the therapists.
Where it's running
-
Swinburne University of Technology
Hawthorn, Victoria, Australia Recruiting
Study contacts
- Principal investigator: Neil Thomas — Swinburne University of Technology
- Study coordinator: Neil Thomas
- Email: neilthomas@swin.edu.au
- Phone: +61 3 92148742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Analyzing speech to predict psychosis in at-risk patients
This study is trying to see if analyzing the way people at high risk for schizophrenia speak can help predict if they will develop psychosis.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Small Soteria-inspired unit vs. standard closed ward for acute psychosis
A randomized or semi-randomized comparison tests whether a small Soteria-style inpatient unit improves outcomes for adults with acute psychosis compared to a conventional closed psychiatric ward.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Racial differences in how people experience paranoia
This project will see if brief race-related stressful experiences increase feelings of paranoia in Black American adults who take online surveys.
-
Yoga-based group program plus usual care for outpatients with schizophrenia spectrum disorders
This project will see if a 12-week yoga-based group program added to usual outpatient care helps adults with schizophrenia spectrum disorders reduce stress and symptom-related distress compared with exercise or usual care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.